Medicare Part D Will Lead To Rx-To-OTC Petitions By CMS, Attorney Predicts
This article was originally published in The Tan Sheet
Executive Summary
Medicare may seek to save on drug costs in the Part D benefit by asking FDA to switch certain drugs from prescription to over-the-counter status, Sidley Austin Brown & Wood attorney Jack Bierig predicted